Education
About Us
Working with TipRanks
Follow Us
Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
HNGE Analyst Ratings
Strong Buy
13 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HNGE Stock 12 Month Forecast
Average Price Target
$60.08
▲(2.06% Upside)
| Highest Price Target$70.00 | Average Price Target$60.08 | Lowest Price Target$50.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
―
Buy
―
Reiterated
09/15/25
Stifel Nicolaus
$63→$66
Buy
12.11%
Upside
Reiterated
09/11/25
Robert W. Baird
$56
Hold
-4.88%
Downside
Initiated
09/04/25
Piper Sandler
$70
Buy
18.91%
Upside
Reiterated
08/25/25
Canaccord Genuity
$61
Buy
3.62%
Upside
Reiterated
08/14/25
TR | OpenAI - 4o
$53→$64
Hold
8.71%
Upside
Reiterated
08/07/25
AI Generated ArticleAI Generated Article
Raymond James
$45→$65
Buy
10.41%
Upside
Reiterated
08/06/25
Needham
$59
Buy
0.22%
Upside
Reiterated
08/06/25
Bank of America Securities
$42→$64
Buy
8.71%
Upside
Reiterated
08/06/25
Morgan Stanley
$46→$57
Buy
-3.18%
Downside
Reiterated
08/06/25
Evercore ISI
$50
Buy
-15.07%
Downside
Reiterated
08/06/25
RBC Capital
$45→$60
Buy
1.92%
Upside
Reiterated
08/06/25
William Blair
―
Buy
―
Reiterated
08/05/25
We recommend investors own HNGE shares on the back of a clean second- quarter beat and strong growth momentum. More specific, we believe Hinge Health is well positioned to capitalize on a strong demand environment for digital MSK solutions, as employers seek cost-savings solutions that also augment the employee experience. The company also continues to extend its market leadership with product innovation (e.g., a network of curated in- person care providers called HingeSelect, announced in mid-June) and new channel partners (e.g., launching with Cigna [CI $270.74] earlier in 2025). The stock has traded well following the IPO, moving up about 50% from the $32 offering price. HNGE shares now trade at approximately 7 times 2026 revenue and 8 times 2026 adjusted gross profit, a discount to mature, high- margin, growth-oriented healthcare IT peers.
Barclays
$51
Buy
-13.37%
Downside
Reiterated
08/04/25
Citizens JMP
$58
Buy
-1.48%
Downside
Initiated
07/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
―
Buy
―
Reiterated
09/15/25
Stifel Nicolaus
$63→$66
Buy
12.11%
Upside
Reiterated
09/11/25
Robert W. Baird
$56
Hold
-4.88%
Downside
Initiated
09/04/25
Piper Sandler
$70
Buy
18.91%
Upside
Reiterated
08/25/25
Canaccord Genuity
$61
Buy
3.62%
Upside
Reiterated
08/14/25
TR | OpenAI - 4o
$53→$64
Hold
8.71%
Upside
Reiterated
08/07/25
AI Generated ArticleAI Generated Article
Raymond James
$45→$65
Buy
10.41%
Upside
Reiterated
08/06/25
Needham
$59
Buy
0.22%
Upside
Reiterated
08/06/25
Bank of America Securities
$42→$64
Buy
8.71%
Upside
Reiterated
08/06/25
Morgan Stanley
$46→$57
Buy
-3.18%
Downside
Reiterated
08/06/25
Evercore ISI
$50
Buy
-15.07%
Downside
Reiterated
08/06/25
RBC Capital
$45→$60
Buy
1.92%
Upside
Reiterated
08/06/25
William Blair
―
Buy
―
Reiterated
08/05/25
We recommend investors own HNGE shares on the back of a clean second- quarter beat and strong growth momentum. More specific, we believe Hinge Health is well positioned to capitalize on a strong demand environment for digital MSK solutions, as employers seek cost-savings solutions that also augment the employee experience. The company also continues to extend its market leadership with product innovation (e.g., a network of curated in- person care providers called HingeSelect, announced in mid-June) and new channel partners (e.g., launching with Cigna [CI $270.74] earlier in 2025). The stock has traded well following the IPO, moving up about 50% from the $32 offering price. HNGE shares now trade at approximately 7 times 2026 revenue and 8 times 2026 adjusted gross profit, a discount to mature, high- margin, growth-oriented healthcare IT peers.
Barclays
$51
Buy
-13.37%
Downside
Reiterated
08/04/25
Citizens JMP
$58
Buy
-1.48%
Downside
Initiated
07/14/25
Best Analysts Covering Hinge Health, Inc. Class A
1 Month
xxx
Success Rate
3/3 ratings generated profit
Average Return
+24.70%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +24.70% per trade.
3 Months
xxx
Success Rate
3/3 ratings generated profit
Average Return
+35.60%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +35.60% per trade.
1 Year
Success Rate
3/3 ratings generated profit
Average Return
+35.60%
reiterated a buy rating 2 months ago
Copying Saket Kalia's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +35.60% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+35.60%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HNGE Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
0
0
0
0
Buy
14
18
32
20
Hold
0
0
3
4
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
14
18
35
24
Each month's total comprises the sum of three months' worth of ratings.
HNGE Financial Forecast
HNGE Stock Forecast FAQ
What is HNGE’s average 12-month price target, according to analysts?
Based on analyst ratings, Hinge Health, Inc. Class A’s 12-month average price target is 60.08.
What is HNGE’s upside potential, based on the analysts’ average price target?
Hinge Health, Inc. Class A has 2.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HNGE a Buy, Sell or Hold?
Hinge Health, Inc. Class A has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.
What is Hinge Health, Inc. Class A’s price target?
The average price target for Hinge Health, Inc. Class A is 60.08. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $70.00 ,the lowest forecast is $50.00. The average price target represents 2.06% Increase from the current price of $58.87.
The highest analyst price target is $70.00 ,the lowest forecast is $50.00. The average price target represents 2.06% Increase from the current price of $58.87.
What do analysts say about Hinge Health, Inc. Class A?
Hinge Health, Inc. Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of HNGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.